MedPath

Osteopathy and Latent Hypothyroidism

Not Applicable
Conditions
Latent Hypothyroidism
Interventions
Other: OMT
Registration Number
NCT02430857
Lead Sponsor
Emanuel Amier Diekmann
Brief Summary

This study evaluates the effectiveness of stimulating the neurological segments c8-th5 in patients with latent hypothyroidism.

One half of the participants will receive an osteopathic manuel treatment in order to stimulate the relevant segments, the other half will receive no treatment.

Detailed Description

Patients with latent hypothyroidism show an increased hormone status in TSH and a normal hormone status in fT4. A study has shown that osteopathic treatment had positive effects to some symptoms in patients with latent hypothyroidism. The study was using the pain inventory as the instrument to measure the effect. In this study we want to evaluate the effectiveness of the treatment on the hormone status (TSH, fT4) The intervention group will receive a neurological osteopathic stimulation over 5 weeks. A parallel control group will not receive any therapy.

A follow up blood screening (TSH, fT4) will be done. The results of both groups will be compared.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
40
Inclusion Criteria
  • latent hypothyroidism
Exclusion Criteria
  • Factors that Alter Thyroxine and Triiodothyronine Binding in Serum
  • Increased thyroxin-binding globulin
  • Decreased thyroxin-binding globulin
  • Binding inhibitors
  • Inherited Salicylates
  • Pregnancy
  • Androgens
  • Furosemide
  • Neonatal state
  • Anabolic steroids
  • Free fatty acids
  • Estrogens
  • Glucocorticoids
  • Phenytoin
  • Hepatitis
  • Severe illness
  • Carbamazepine
  • Porphyria
  • Hepatic failure
  • nonsteroidal antiinflammatory drug (variable, transient)
  • Heroin
  • Nephrosis
  • Heparin
  • Methadone
  • Nicotinic acid
  • Mitotane L-Asparaginase
  • 5-Fluorouracil
  • SERMS (e.g., tamoxifen, raloxifene)
  • Perphenazine
  • spinal pathologies

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
OMT-GroupOMTThe OMT-group will get an osteopathic treatment once a week for 1 hour for 5 weeks. The blood will be screened again after the treatment.
Primary Outcome Measures
NameTimeMethod
Change in TSH Concentration5 weeks
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath